Simulations Plus, Inc. · NASDAQ:SLP
Simulations Plus — Shareholder Meeting (February 2007)
21 slides from Simulations Plus's shareholder meeting presentation, Feb 26, 2007
Slide 1: Agenda: 1Q 2007 summary, strategy, Q&A
~1.8 MM shares (9 trading days) -Record close at $7.05 on Friday •Agenda -1Q 2007 summary (September 1 -November 30, 2006) -Strategy going forward -Questions and Answers
Slide 2: Management & Directors
Management & Directors •Board of directors: -Walter S. Woltosz, M.S., M.A.S., Chairman & CEO. •Co-founder, Words+, Inc. and Simulations Plus, Inc. -David Z. D’Argenio, Ph.D., Director •Professor, Biomedical Engineering, USC •Director, Co-Director, Biological Simulation Resource Center, USC since 198
Slide 3: Outside Counsels
Outside Counsels •Rose, Snyder, Jacobs - Registered Independent Auditors •Luce, Forward, Hamilton & Scripps - Legal Counsel
Slide 4: Discussion of Voting Issues
Discussion of Voting Issues Candidates for Board of Directors remains unchanged: • • David Z. D’Argenio, Ph.D. • Richard R. Weiss, Ph.D. • Virginia E. Woltosz, MBA • Walter S. Woltosz, MS, MAS • • Outside auditor: • • Rose, Snyder, Jacobs • • 2007 Stock Option Plan • • There are no other voting issu
Slide 5: Chairman's Remarks
Chairman’s Remarks •Company Overview • • Words+, Inc. • • Simulations Plus, Inc. • • Financial Performance
Slide 6: Safe Harbor Statement Under the Private Securities Litigation Act 1995
Safe Harbor Statement Under the Private Securities Litigation Act 1995 With the exception of historical information, the matters discussed in this presentation are forward looking statements that involve a number of risks and uncertainties. The actual results of the Company could differ significantl
Slide 7: Words+ Overview
Words+ Overview •Words+, Inc. -Assistive technology products for disabled •Hardware •Software •Support products -Global business founded 1981 - pioneer business -Technology leader and innovator for 25 years -Provides synergy and overhead cost-sharing with pharmaceutical/biotech business •Windows ope
Slide 8: Factors Affecting Words+ Sales
Factors Affecting Words+ Sales •Acquisition of Say-it! SAM technology in December 2003 -Hardware and software for PDA-based communication device -Software now translated to full-size Windows XP computers • •Competition is very strong -A number of smaller companies have entered the market -Some have
Slide 9: Words+ Growth Strategies
Words+ Growth Strategies •Increase product awareness -Workshops, conferences -Alliances with key clinicians and educators -E-mail, web site, multi-media (CD-ROM video) •Increase dealer effectiveness -Continue to work toward expanding dealer/representative network -Training and monitoring programs to
Slide 10: Simulations Plus Overview
Simulations Plus Overview •Simulations Plus, Inc. -Software for pharmaceutical research •ADMET Predictor™ •ClassPharmer™ •DDDPlus™ •GastroPlus™ •MembranePlus™ (in development) -Contract services
Slide 11: Improving our Solutions
Improving our Solutions •ADMET Predictor™ -Additional property predictions, user convenience features -Merged with ADMET Modeler to provide integrated product •DDDPlus™ -Version 2.0 incorporates suggested changes from large number of evaluators -No competition - new product area -Prior to this fisca
Slide 12: Contract Services
Contract Services •Rapid growth in demand for contract services this fiscal year -In prior years, 1-3 studies were typical for the entire year -Now 5-6 studies either under way or in quotation stage almost continually •Studies provide opportunities for our scientists to think and work like our custo
Slide 13: New Initiatives
New Initiatives •MembranePlus™ -Simulation of laboratory permeability experiments -This project was put on hold due to staff changes and priorities on GastroPlus. It will be resumed as soon as new staff are hired into the Simulation Technologies team (one new Ph.D. begins in March). •Small Business
Slide 14: New Initiatives
New Initiatives + MembranePlus™ — Simulation of laboratory permeability experiments — This project was put on hold due to staff changes and priorities on GastroPlus. It will be resumed as soon as new staff are hired into the Simulation Technologies team (one new PhD. begins in March). + Small Busine
Slide 15: Selected Income Statement Data
Selected Income Statement Data (in millions except per share data) 1Q Ended 11/30/06 1Q Ended 11/30/05 4Q Ended 8/31/06 4Q Ended 8/31/05 3Q Ended 5/31/06 3Q Ended 5/31/05 Revenues $1.456 $0.818 $1.766 $1.230 $1.788 $1.424 Cost of Sales 0.441 0.332 0.452 0.387 0.433 0.428 Gross Profit 1.015 0.487 1.3
Slide 16: Balance Sheet
Balance Sheet (in millions) As of November 30, 2006 ASSETS LIABILITIES Cash & cash equivalents $ 2.103* Accounts payable $ 0.141 Accounts receivable 1.214 Accrued expenses 0.419 Other current assets 0.667 Current portion deferred revenue 0.157 TOTAL CURRENT ASSETS 3.984 Other current liabilities - T
Slide 17: Market Profile
Market Profile* •Symbol: AMEX: SLP •Recent Price: $8.91 ($1.75 last year adjusted for split) •Average Daily Volume (3 mo avg): 109,282 (9,954 last year) •12 Month Price Range: $ 1.73 - 9.65 (split-adjusted) •52-week change: 415% •P/E (ttm 11/30/06) ~ 79.55 (23.38 last year) -Analyst’s projected P/E
Slide 18: Investment Highlights
Investment Highlights •Emerging, high-growth market •Proprietary multi-platform software •Recurring revenue business model •Fast-growing and profitable •Debt-free •Excellent cash position •Experienced management team and board •Highly talented and dedicated workforce in both Words+ and Simulations P
Slide 19: Questions and Answers
Questions and Answers Opportunity for shareholders to ask questions about the company. Please understand that we cannot provide any information that would be considered “insider information” - information that would provide those attending this meeting with knowledge about company operations that wo
Slide 20: Simulations Plus, Inc.
Simulations Plus, Inc. Increasing shareholder value by providing competitive advantages to our customers in the pharmaceutical, biotech, and disability industries
Slide 21: Simulations Plus, Inc.
Simulations Plus, Inc. Increasing shareholder value by providing competitive advantages to our customers in the pharmaceutical, biotech, and disability industries simulationsplus, inc. Of
Simulations Plus — Shareholder Meeting (February 2007) on 6ix